An attempt was made to use simple cationic
liposomes DC-Chol/DOPE and
DDAB/DOPE (
DC-Chol is 3 beta (N(N',N-dimethylaminoethane) carbamoyl)
cholesterol,
DDAB is dimethyldioctadecyl
ammonium bromide and DOPE is
dioleoylphosphatidylethanolamine) for transfer of Escherichia coli
cytosine deaminase 'suicide' gene under the control of tissue-specific
tyrosinase gene promoter directly into the murine
melanoma B16(F10)
tumor. Several repeated intratumoral
injections of
DNA-
liposome complexes followed by intraperitoneal administrations of
5-fluorocytosine, which is converted to
5-fluorouracil, caused strong retardation of murine
melanoma B16(F10)
tumor growth and, in some cases, rejection of the pre-established
tumor. The inhibition of
tumor growth expressed as the increased survival of mice is better seen in the case of using
DNA-
DDAB/DOPE complexes as compared to
DNA-
DC-Chol/DOPE ones. It seems that the observed
therapeutic effect appears to result from several factors:
5-fluorouracil generation by transfected cells,
liposome toxicity (
DDAB is more toxic than
DC-Chol and hence more
tumor cells are killed), increased transfection efficiency of surviving
cancer cells (in this case
DDAB is a better transfection agent than
DC-Chol) and, finally, the bystander effect which causes destruction of cells untransfected with CD gene by easily diffusible
5-fluorouracil.